Pentraxin 3: A promising therapeutic target for autoimmune diseases.

Autoimmunity Reviews
Qian WuHai-Feng Pan

Abstract

Pentraxin 3 (PTX3) is a prototypic humoral soluble pattern recognition molecule that exerts a pivotal role in innate immune response and inflammation, as well as in tissue damage and remodeling. Recently, emerging evidence has revealed that PTX3 is involved in the occurrence and development of various autoimmune diseases, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), ankylosing spondylitis (AS), systemic sclerosis (SSc), inflammatory bowel disease (IBD), multiple sclerosis (MS) and psoriasis, etc. In this review, we have succinctly summarized the complex immunological functions of PTX3 and mostly focused on recent findings of the pleiotropic activities played by PTX3 in the pathogenesis of autoimmune diseases, aiming at hopefully offering possible future therapeutic alternatives.

References

Dec 22, 1999·Clinical and Experimental Immunology·M M LuchettiA Gabrielli
Aug 3, 2000·The New England Journal of Medicine·R Medzhitov, C Janeway
Jan 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Benedetta BussolatiGiovanni Camussi
Mar 21, 2003·European Journal of Immunology·Alma J NautaAnja Roos
Apr 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Song Guo ZhengDavid A Horwitz
Nov 9, 2004·Trends in Immunology·C Yung Yu, Caroline C Whitacre
Jan 28, 2005·Kidney International·Alma J NautaAnja Roos
Mar 18, 2005·Annual Review of Immunology·Cecilia GarlandaAlberto Mantovani
Apr 18, 2006·Journal of Leukocyte Biology·Paramita BaruahPatrizia Rovere-Querini
Aug 5, 2006·The American Journal of Medicine·Andrea DoriaSilvano Todesco
Mar 29, 2007·The Journal of Experimental Medicine·Sébastien JaillonAlberto Mantovani
Apr 24, 2007·Lancet·Jürgen Braun, Joachim Sieper
Sep 1, 2007·Journal of Cellular and Molecular Medicine·Marco PrestaMarco Rusnati
Nov 9, 2007·Digestive Diseases and Sciences·Shingo KatoKoji Yakabi
May 20, 2008·Autoimmunity Reviews·Jesús CastroMiquel Vilardell-Tarrés
Oct 31, 2008·Lancet·Alastair Compston, Alasdair Coles
Dec 4, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Livija DebanSeppo Meri
Feb 14, 2009·Rheumatology·Jean-François AugustoJean-François Subra
Feb 24, 2009·Arthritis Research & Therapy·Joachim Sieper
Mar 11, 2009·The Journal of Rheumatology·Yohei IwataShinichi Sato
Apr 16, 2009·Clinical Microbiology Reviews·Trine H Mogensen
Dec 9, 2009·Annual Review of Immunology·Barbara BottazziAlberto Mantovani
Mar 9, 2010·Nature Immunology·Livija DebanAlberto Mantovani
Apr 7, 2010·The Journal of Biological Chemistry·Antonio InforzatoAnthony J Day
Apr 15, 2010·Arthritis Care & Research·Ivana HollanUNKNOWN Feiring Heart Biopsy Study Group
May 5, 2010·Annals of the Rheumatic Diseases·N BassiA Doria
Apr 20, 2011·Pathology International·Alexander S SavchenkoMakoto Naito
Nov 1, 2011·Immunity·Thomas S Griffith, Thomas A Ferguson
Feb 23, 2012·Autoimmunity Reviews·Juan-Manuel Anaya

❮ Previous
Next ❯

Citations

Nov 1, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Peng WangZong-Wen Shuai
Mar 17, 2021·Autoimmunity Reviews·Rui ZhaoChongbo Zhao
Jun 13, 2021·Autoimmunity Reviews·Kun XiangDe-Guang Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.